| XLS |
|
|
|
|
|
||
|
€ million |
Note |
2013 |
2012 |
||
|
|||||
|
Profit after tax |
|
1,209.1 |
579.0 |
||
|
Depreciation/amortization/impairment losses/reversals of impairments |
|
1,458.4 |
1,396.6 |
||
|
Changes in inventories |
|
–58.4 |
140.6 |
||
|
Changes in trade accounts receivable |
|
–45.0 |
186.2 |
||
|
Changes in trade accounts payable |
|
128.2 |
198.8 |
||
|
Changes in provisions |
|
–203.0 |
378.6 |
||
|
Changes in other assets and liabilities |
|
–260.4 |
–383.5 |
||
|
Neutralization of gain/loss on disposals of assets |
|
–27.5 |
–31.6 |
||
|
Other non-cash income and expenses |
|
24.1 |
7.5 |
||
|
Net cash flows from operating activities |
[53] |
2,225.5 |
2,472.2 |
||
|
|
|
|
|
||
|
Investments in intangible assets |
|
–109.6 |
–144.2 |
||
|
Investments in property, plant and equipment |
|
–407.0 |
–329.1 |
||
|
Acquisitions |
|
–15.1 |
–20.6 |
||
|
Investments in non-current financial assets |
|
–15.0 |
–72.41 |
||
|
Investments in current financial assets |
|
–625.6 |
–685.21 |
||
|
Disposal of non-current assets |
|
297.8 |
93.6 |
||
|
Net cash flows from investing activities |
[54] |
–874.5 |
–1,157.9 |
||
|
|
|
|
|
||
|
Dividend payments to Merck KGaA shareholders |
|
–109.9 |
–96.91 |
||
|
Dividend payments to non-controlling interests |
|
–3.7 |
–5.71 |
||
|
Dividend payments to E. Merck KG |
|
–304.5 |
–326.51 |
||
|
New borrowings of financial liabilities from E. Merck KG |
|
128.8 |
32.61 |
||
|
Payments from transactions with no change of control |
|
–0.3 |
–15.0 |
||
|
Repayment of bonds |
|
–750.0 |
–1,000.0 |
||
|
New borrowings of other current and non-current financial liabilities |
|
64.6 |
37.5 |
||
|
Repayments of other current and non-current financial debt liabilities |
|
–97.7 |
–145.4 |
||
|
Net cash flows from financing activities |
|
–1,072.7 |
–1,519.4 |
||
|
|
|
|
|
||
|
Changes in cash and cash equivalents |
|
278.3 |
–205.1 |
||
|
Changes in cash and cash equivalents due to currency translation |
|
–27.2 |
–3.0 |
||
|
Cash and cash equivalents as of January 1 |
|
729.7 |
937.8 |
||
|
Cash and cash equivalents as of December 31 |
|
980.8 |
729.7 |
||
|
Plus cash and cash equivalents included in assets held for sale |
|
– |
– |
||
|
Cash and cash equivalents as of December 31 (consolidated balance sheet) |
[35] |
980.8 |
729.7 |
||